Loading...

Anebulo Pharmaceuticals, Inc.

ANEB•NASDAQ
Healthcare
Biotechnology
$0.46
$-0.04(-8.76%)
U.S. Market opens in 11h 19m

Anebulo Pharmaceuticals, Inc. (ANEB) Stock Overview

Explore Anebulo Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap18.8M
P/E Ratio-2.37
EPS (TTM)$-0.18
ROE-0.75%
Fundamental Analysis

AI Price Forecasts

1 Month$0.54
3 Months$1.20
1 Year Target$1.01

ANEB Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Anebulo Pharmaceuticals, Inc. (ANEB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.53, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.37 and a market capitalization of 18.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-8.76%
5-Day Change
4.55%
1-Month Change
-33.33%
3-Month Change
-43.98%
6-Month Change
-81.89%
Year-to-Date (YTD) Change
-54.46%
1-Year Change
-60.00%
3-Year Change
-81.07%
5-Year Change
-93.52%
All-Time (Max) Change
-93.52%

Contact Information

https://www.anebulo.com
512 598 0931
1415 Ranch Road 620 South, Lakeway, TX, 78734

Company Facts

2 Employees
IPO DateMay 7, 2021
CountryUS
Actively Trading

Frequently Asked Questions